objective(s) extended-spectrum beta-lactamase (esbl) producing bacteria have an important role in nosocomial infections. due to the limited availability of information about the molecular epidemiology of esbl producing bacteria in mashhad, we decided to investigate about tem, ctx and shv esbls among urinary escherichia coli isolates in mashhad, a city in northeast iran. materials and methods   ...

introduction: this study is aimed to compare phenotypic test methods and determine antibiotic susceptibility pattern of ampc beta-lactamase producing uropathogenic escherichia coli and klebsiella pneumoniae in clinical isolates. method: e. coli and k. pneumoniae were identified by standard microbiological procedures. screening of ampc beta-lactamase production was done by using cefoxitin disc (...

Beta-lactamase enzymes (BLs) have become the most worrisome mediators of antimicrobial resistance expressed by gram-negative bacteria (GNB). The multiple families of BLs have in common the ability to hydrolyze the -lactam rings of one or more members of the penicillins, cephalosporins, cephamycins, carbapenems, and monobactams. Extended-spectrum -lactamases (ESBLs) are a subset of BLs that conf...

At least 30 extended-spectrum beta-lactamases (ESB) have emerged responsible for resistance to indigestible beta-lactams (C3G) since their discovery in West Germany in 1983. Most of them are produced by enterobacteria and essentially K. pneumoniae which appeared susceptible to oxyimino-beta-lactams. A double-disk test was useful to detect such nosocomial isolates of enterobacteria (urines, bloo...

Extended spectrum beta-lactamases (ESBLs) are enzymes produced by bacteria, mostly members of the family Enterobacteriaceae commonly Escherichia coli and Klebsiella pneumoniae. ESBLs hydrolyze beta-lactam ring antibiotics making these ineffective therefore rendering bacteria resistance against antibiotics. The global upsurge producing causing both hospital community acquired infections urinary ...